HPV- and herpes virus infections: epidemiological, pathogenetic and clinical immunological aspects, principles of diagnosis and therapy
https://doi.org/10.17749/2313-7347.2020.14.1.102-111
Abstract
The article describes the current issues of the epidemiology of human papillomavirus infection of high carcinogenic risk and genital herpes, affecting reproductive health. The attention is focused on modern principles of diagnosis and treatment, including approaches to immunotherapy and combination therapy.
About the Authors
G. Kh. Vikulov
People’s Friendship University of Russia; Scientific Information Center for the Prevention and Treatment of Viral Infections; Herpetic Center of the Clinic Doctor.Prof.
Russian Federation
Russian Federation
Georgiy Kh. Vikulov - MD, PhD, Assistant, Department of Infectious Diseases, PFUR; Director of SIC for the Prevention and Treatment of Viral Infections; Herpetic CHC Doctor.Prof, Scopus Author ID: 41462029100, Researcher ID: W-9315-2018.
6 Miklukho-Maklaya St., Moscow 117198; 138, 12 bild. 1, Konakovskiypassage, Moscow 125565; 6 bild. 2, Proektiruemyi driveway 4062, Moscow 115432
S. L. Voznesenskiy
People’s Friendship University of Russia
Russian Federation
Russian Federation
Sergey L. Voznesenskiy - MD, PhD, Associate Professor, Department of Infectious Diseases.
6 Miklukho-Maklaya St., Moscow 117198
D. I. Frolkin
Pirogov Russian National Research Medical University, Health Ministry of Russian Federation
Russian Federation
Russian Federation
Denis I. Frolkin - 6th year Student, Pirogov Russian National Research Medical University, Moscow, Russia.
1 bild. 7, Ostrovityanova St., Moscow 117997
References
1. Moustafa A., Xie C., Kirkness E. et al. The blood DNA virome in 8,000 humans. PLoS Pathog. 2017;13(3):e1006292. DOI: 10.1371/journal.ppat.1006292.
2. Molochkov A.V., Khlebnikova A.N., Bagramova G.E., Gureeva M.A. Antiviral therapy for genital papillomavirus infection. [Protivovirusnaya terapiya v lechenii genital’noj papillomavirusnoj infekcii]. Effektivnaya farmakoterapiya. 2011;(11):24-6. (In Russ.).
3. Makatsariya A.D., Bitsadze V.O., Khizroeva J.Kh. et al. Efficacy and safety of glucosaminylmuramyl dipeptide in treatment of human papillomavirus-associated diseases: a systematic review. [Effektivnost’ i bezopasnost’ glyukozaminilmuramildipeptida v lechenii zabolevanij, associirovannyh s virusom papillomy cheloveka: sistematicheskij obzor]. Akusherstvo, ginekologiya ireprodukciya. 2019;13(2):132-54. (In Russ.). DOI: 10.17749/2313-7347.2019.13.2.132-154.
4. Yang X., Cheng Y., Li C. The role of TLRs in cervical cancer with HPV infection: a review. Signal Transduct Target Ther. 2017;2:17055. DOI: 10.1038/sigtrans.2017.55.
5. Zhou C., Tuong Z.K., Frazer I.H. Papillomavirus immune evasion strategies target the infected cell and the local immune system. Front Oncol. 2019;9:682. DOI: 10.3389/fonc.2019.00682.
6. Fisman D.N., Lipsitch M., Hook E.W., Goldie SJ. Projection of the future dimensions and costs of the genital herpes simplex virus type 2 epidemic in the United States. Sex Transm Dis. 2002;29(10):608-22. DOI: 10.1097/00007435-200210000-00008.
7. Bebneva T.N., Khamoshina M.B., Tulupova M.S. et al. Genital herpes in practice of gynecologist: complicated questions - simple answers. [Genital’nyj gerpes v praktike ginekologa: slozhnye voprosy - prostye otvety]. Akusherstvo i ginekologiya: novosti mneniya, obuchenie. 2019;7(3):112-9. (In Russ.). DOI: 10.24411/2303-9698-2019-13017.
8. Vikulov G., Voznesenskiy S. Combination antiviral therapy of herpes simplex. [Kombinirovannaya protivovirusnaya terapiya prostogo gerpesa]. Vrach. 2019;30(5):27-34. (In Russ.). DOI: 10.29296/25877305-2019-05-0534.
9. Khaldin A.A., Baskakova D.V. Epidemiological aspects of diseases caused by the herpes simplex virus (review). [Epidemiologicheskie aspekty zabolevanij, vyzyvaemyh virusom prostogo gerpesa (obzor literatury)]. Dermatologiya. Consilium Medicum. 2007;(1):22—5. (In Russ.).
10. Virology guide. Viruses and viral infections of humans and animals. Ed. Acad. RAS D.K. Lvov. [Rukovodstvo po virusologii. Virusy i virusnye infekcii cheloveka i zhivotnyh. Pod red. akad. RAN D.K. L’vova]. Moskva: MIA, 2013. 1200 s. (In Russ.).
11. Vikulov G.Kh. Clinical and immunological characteristics of herpesvirus infections in individuals exposed to the radiation factor in the period remote after irradiation: [Kliniko-immunologicheskaya harakteristika gerpesvirusnyh infekcij u lic, podvergavshihsya vozdejstviyu radiacionnogo faktora v otdalennom posle oblucheniya periode]. Avtoref. dis. kand. med. nauk. Moskva, 2009. 24 s. (In Russ.).
12. Prilepskaya V.N., Dovletkhanova E.R., Abakarova P.R. Treatment options for HPV-associated genital diseases in women. [Vozmozhnosti terapii VPCh-associirovannyh zabolevanij genitalij u zhenshchin]. Akusherstvo iginekologiya. 2011;(5):123—8. (In Russ.).
13. De Vuyst H., Clifford G., Li N., Franceschi S. HPV infection in Europe. Eur J Cancer. 2009;45(15):2632-9. DOI: 10.1016/j.ejca.2009.07.019.
14. Savchenko A.A., Tskhai V.B., Kruglova D.Yu., Borisov A.G. Immunological parameters in patients with monoinfection by human papillomavirus and in patients co-infected by papillomavirus and urogenital pathogens. [Immunologicheskie pokazateli pri monoinfekcii virusom papillomy cheloveka i sochetannoj papillomavirusnoj i urogenital’noj infekcii]. Infekciya iimmunitet. 2014;4(3):241—8. (In Russ.).
15. Guidry J.T., Scott R.S. The interaction between human papillomavirus and other viruses. Virus Res. 2017;231:139-47. DOI: 10.1016/j.virusres.2016.11.002.
16. Dermatovenerology. National leadership. Eds. Yu.S. Butova, Yu.K. Skripkina, O.L. Ivanova [Dermatovenerologiya. Nacional’noe rukovodstvo. Pod red. Yu.S. Butova, Yu.K. Skripkinoj, O.L. Ivanovoj]. Moskva: GEOTAR-Media, 2013. 896 s. (In Russ.).
17. Clinical guidelines for the diagnosis and treatment of adult patients with genital warts of the perianal region and anal canal. [Klinicheskie rekomendacii po diagnostike i lecheniyu vzroslyh pacientov s ostrokonechnymi kondilomami perianal’noj oblasti i anal’nogo kanala]. Moskva, 2013. 16 s. (In Russ.). Available at: https://mzdrav.rk.gov.ru/file/Ostrokonechnye_kondilomy_18042014_Klinicheskie_rekomendacii.pdf. (Accessed: 12.11.2019).
18. Federal clinical guidelines for the management of patients with anogenital (venereal) warts. [Federal’nye klinicheskie rekomendacii po vedeniyu bol’nyh anogenital’nymi (venericheskimi) borodavkami]. Moskva, 2015. 16 s. (In Russ.). Available at: https://www.ismos.ru/guidelines/doc/anogenital’nye_borodavki.pdf. (Accessed: 12.11.2019).
19. Wesrtich J.A., Warren C.J., Pyeon D. Evasion of host immune defenses by human papillomavirus. Virus Res. 2017;231:21-33. DOI: 10.1016/j.virusres.2016.11.023.
20. Saslow D., Solomon D., Lawson H.W. et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol. 2012;137(4):516-42. DOI: 10.1309/AJCPTGD94EVRSJCG.
21. Bebneva T.N. Key player. The use of immunotherapy in obstetrics and gynecology: examples from clinical practice. Newsletter. Ed. V.E. Radz-insky. [Klyuchevoj igrok. Ispol’zovanie immunoterapii v akusherstve i ginekologii: primery iz klinicheskoj praktiki. Informacionnyj byulleten’. Pod red. V.E. Radzinskogo]. Moskva: Redakciya zhurnala StatusPraes-ens, 2019. 16 s. (In Russ.).
22. Order of the Ministry of Health of the Russian Federation dated March 13, 2019 No. 124н “On approval of the procedure for conducting preventive medical examination and medical examination of certain groups of the adult population”. [Prikaz Ministerstva zdravoohraneniya RF ot 13 marta 2019 g. № 124n «Ob utverzhdenii poryadka provedeniya profilakticheskogo medicinskogo osmotra i dispanserizacii opredelen-nyh grupp vzroslogo naseleniya»]. Moskva, 2019. (In Russ.). Available at: http://docs.cntd.ru/document/554018402. (Accessed: 12.11.2019).
23. Clinical recommendations. Obstetrics and gynecology. Eds. V.N. Serov, G.T. Sukhikh. [Klinicheskie rekomendacii. Akusherstvo i ginekologiya. Pod red. V.N. Serova, G.T. Suhih]. Moskva: GEOTAR-Media, 2014. 1024 s. (In Russ.). Available at: https://www.rosmedlib.ru/book/ISBN9785970427576.html. (Accessed: 12.11.2019).
24. Clinical recommendations. Herpes simplex in adults. National Scientific Society of Infectious Diseases (NNOI). [Klinicheskie rekomendacii. Prostoj gerpes u vzroslyh. Nacional’noe nauchnoe obshchestvo infekcionistov (NNOI)]. Moskva, 2014. 129 s. (In Russ.). Available at: http://nnoi.ru/uploads/files/protokoly/Herp_simp_adult.pdf. (Accessed: 12.11.2019) .
25. Clinical recommendations (treatment protocol) for providing medical care to adult herpes simplex patients. International Association of Specialists in Infectious Diseases (MASOI). [Klinicheskie rekomendacii (protokol lecheniya) okazaniya medicinskoj pomoshchi vzroslym bol’nym prostym gerpesom. Mezhdunarodnaya associaciya specialistov po infekcionnym boleznyam (MASOI)]. Moskva, 2016. 129 s. (In Russ.). Available at: http://www.iia-rf.ru/upload/iblock/3d3/3d3279b6801b916b7a1b0b52159e7755.pdf. (Accessed: 12.11.2019).
26. Federal clinical guidelines. Dermatovenerology 2015: Skin diseases. Sexually transmitted infections. 5th ed. [Federal’nye klinicheskie rekomendacii. Dermatovenerologiya 2015: Bolezni kozhi. Infekcii, peredavaemye polovym putem. 5-e izd., pererab. i dop]. Moskva: Delovoj ekspress, 2016. 768 s. (In Russ.). Available at: https://cnikvi.ru/docs/2335_maket_30.pdf. (Accessed: 12.11.2019).
27. Isakov V.A., Arkhipova E.I., Isakov D.V. Human herpesvirus infections. A guide for physicians. [Gerpesvirusnye infekcii cheloveka. Rukovodstvo dlya vrachej]. SPb.: SpecLit, 2013. 16 s. (In Russ.). Available at: https://speclit.su/image/catalog/978-5-299-00454-0/978-5-299-00454-0.pdf. (Accessed: 12.11.2019) .
28. Vikulov G.Kh. Immunological aspects of herpesvirus infections. [Immunologicheskie aspekty gerpesvirusnyh infekcij]. Klinicheskaya dermatologiya i venerologiya. 2015;14(5):104-16. (In Russ.).
29. Petrunin D.D. The use of interferon alfa drugs for the treatment of urogenital infections. [Ispol’zovanie preparatov interferona al’fa dlya lecheniya urogenital’nyh infekcij]. AG-info. 2009;(2):6-12. (In Russ.).
30. Prilepskaya V.N., Rogovskaya S.I., Bebneva T.N. et al. The use of interferon preparations in the treatment of squamous cervical lesions of low degree. [Primenenie preparatov interferona pri lechenii ploskokletochnyh intraepitelial’nyh porazhenij shejki matki nizkoj stepeni]. AG-info. 2008;(3):15-21. (In Russ.).
31. Jach R., Basta A., Szczudrawa A. Role of immunomodulatory treatment with Iscador QuS and Intron A of women with CIN1 with concurrent HPV infection. Ginekol Pol. 2003;74(9):729-35.
32. Drolet M., Benard E., Perez N. et al. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet. 2019;394(10197):497-509. DOI: 10.1016/S0140-6736(19)30298-3.
33. Ledina A.V., Ipastova I.D. Modern possibilities of immunotherapy. Effective combined treatment strategies for HPV-associated genital diseases: news bulletin. Ed. V.E. Radzinsky. [Sovremennye vozmozhnosti immunoterapii. Effektivnye strategii kombinirovannogo lecheniya VPCh-associirovannyh genital’nyh zabolevanij: informacionnyj byulleten’. Pod red. V.E. Radzinskogo]. Moskva: Redakciya zhurnala StatusPraesens, 2017. 24 s. (In Russ.).
34. Patel R., Kennedy O.J., Clarke E. et al. 2017 European guidelines for the management of genital herpes. Int J STD AIDS. 2017;28(14):1366-79. DOI: 10.1177/0956462417727194.
35. Gilson R., Nugent D., Werner R.N., Ballesteros J. 2018 European guideline for the management of anogenital warts. 2019. 33 s. Available at: https://www.iusti.org/regions/Europe/pdf/2019/IUSTIguidelinesHPV2019.pdf. (Accessed: 12.11.2019).
36. Pankratov O.V. Immunomodulators in therapy of herpes simplex virus infection. [Immunomodulyatory v lechenii gerpeticheskoj infekcii, vyzvannoj virusom prostogo gerpesa. Medicinskie novosti. 2011;(4):18-24. (In Russ.). Available at: https://cyberleninka.ru/article/n/immunomodulyatory-v-lechenii-gerpeticheskoy-infektsii-vyzvannoy-virusom-prostogo-gerpesa/viewer. (Accessed: 12.11.2019).
37. Committee on New Directions in the Study of Antimicrobial Therapeutics: Immunomodulation. Washington, DC: National Academies Press, 2006. 103 p.
Review
For citations:
Vikulov G.Kh., Voznesenskiy S.L., Frolkin D.I. HPV- and herpes virus infections: epidemiological, pathogenetic and clinical immunological aspects, principles of diagnosis and therapy. Obstetrics, Gynecology and Reproduction. 2020;14(1):102-111. (In Russ.) https://doi.org/10.17749/2313-7347.2020.14.1.102-111
Views:
1612
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
